Abstract
The cobalt-chromium everolimus-eluting stent (CoCr-EES) is the second-generation DES demonstrating the improved safety and efficacy as compared with first-generation drug-eluting stents. Late adverse events such as very late stent thrombosis (VLST) or late target lesion revascularization (TLR) after
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
